The US Food and Drug Administration has approved a single-use at-home test which can detect three STIs in women. Read on to ...

The U.S. Food and Drug Administration granted marketing authorization for the first home-based, nonprescription diagnostic test for chlamydia, gonorrhea, and trichomoniasis in women, the agency ...

The FDA has granted Fast Track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.

For all treated chlamydia infections, 14.0% of patients received doxycycline—the CDC's recommended treatment—alone or with ...

Sanofi SNY announced that the FDA has granted a fast-track designation to its mRNA vaccine candidate for the prevention of ...

Across primary care practices, guideline adherence remains suboptimal for chlamydia and gonorrhea, according to a study ...

Sanofi will soon commence a Phase I/II trial with its vaccine candidate to start generating immunogenicity data.

The only jurisdiction with a higher total rate of STIs than Jackson County in 2024 was St. Louis City. Missouri’s rates of ...

Chlamydia vaccine candidate granted fast track designation by the US FDAChlamydia infection can contribute to pelvic inflammatory diseases in ...

Chlamydia infection can contribute to pelvic inflammatory diseases in women, which can lead to pregnancy complications or infertility A phase 1/2 clinical study evaluating the immunogenicity and ...

The FDA announced Friday that it had approved the first at-home test for sexually transmitted infections, opening the pathway for more to come.

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer nationwide a U.S. Food and Drug Administration (FDA) approved human ...